Opioid Peptides Directly Modulate Inner Ear Nerve Receptors Involved in Balance and Hearing
Endomorphin-1 and dynorphin A directly modulated alpha9/alpha10 nicotinic acetylcholine receptors in the auditory system, providing a molecular mechanism for how opioid peptides affect hearing and balance.
Quick Facts
What This Study Found
Endomorphin-1 and dynorphin A directly modulated alpha9/alpha10 nicotinic ACh receptors (not through opioid receptors), providing a molecular mechanism for opioid peptide modulation of auditory and vestibular function.
Key Numbers
How They Did This
In-vitro electrophysiology study expressing alpha9/alpha10 nAChR in Xenopus oocytes. Direct effects of endomorphin-1 and dynorphin A on receptor currents measured by two-electrode voltage clamp.
Why This Research Matters
Hearing loss and balance disorders are common. Understanding that opioid peptides directly modulate inner ear receptors could explain certain hearing conditions and guide treatment development.
The Bigger Picture
Opioid peptides have effects beyond opioid receptors. Their direct modulation of nicotinic receptors in the inner ear reveals a new dimension of opioid neuropharmacology relevant to sensory processing.
What This Study Doesn't Tell Us
Heterologous expression system (oocytes). The physiological concentrations of opioid peptides at auditory synapses are unknown. Functional hearing/balance consequences not measured.
Questions This Raises
- ?Do opioid drugs affect hearing through this mechanism?
- ?Is this relevant to opioid-induced hearing loss?
- ?Could opioid peptide modulation of inner ear receptors be exploited therapeutically for hearing disorders?
Trust & Context
- Key Stat:
- Direct receptor modulation Endomorphin-1 and dynorphin A directly affected hearing/balance receptors WITHOUT using opioid receptors — a novel non-opioid mechanism for opioid peptides
- Evidence Grade:
- Preliminary in-vitro evidence from a heterologous expression system demonstrating a novel receptor interaction for opioid peptides.
- Study Age:
- Published in 2002. Non-opioid receptor effects of opioid peptides continue to be discovered, expanding understanding of their pharmacology.
- Original Title:
- The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear.
- Published In:
- Molecular and cellular neurosciences, 20(4), 695-711 (2002)
- Authors:
- Lioudyno, M I, Verbitsky, M, Glowatzki, E, Holt, J C, Boulter, J, Zadina, J E, Elgoyhen, A B, Guth, P S
- Database ID:
- RPEP-00747
Evidence Hierarchy
Frequently Asked Questions
Can opioids affect hearing?
This study shows opioid peptides directly interact with the main nerve receptor in the inner ear. This could explain why some opioid users experience hearing changes and opens new understanding of inner ear pharmacology.
Is this different from normal opioid effects?
Yes — this is a non-classical mechanism. The opioid peptides affect the hearing receptor directly, not through their usual opioid receptors. This means their auditory effects use a completely different molecular pathway.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00747APA
Lioudyno, M I; Verbitsky, M; Glowatzki, E; Holt, J C; Boulter, J; Zadina, J E; Elgoyhen, A B; Guth, P S. (2002). The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear.. Molecular and cellular neurosciences, 20(4), 695-711.
MLA
Lioudyno, M I, et al. "The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear.." Molecular and cellular neurosciences, 2002.
RethinkPeptides
RethinkPeptides Research Database. "The alpha9/alpha10-containing nicotinic ACh receptor is dire..." RPEP-00747. Retrieved from https://rethinkpeptides.com/research/lioudyno-2002-the-alpha9alpha10containing-nicotinic-ach
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.